PT Phapros Tbk

Rp 264.00As of Sun 8 Nov 2026, 12:00 UTC
IDX:PEHAHealthcare
Country Indonesia
PE (Fwd) •••
TSR 8Y CAGR (24.32%)
Div yield 1.90%
ROE 11.94%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.47
PE TTM 4.268
TSR TTM (18.39%)
Mkt cap Rp 221.8B
ROIC 9.84%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 296
12.20%
(38.28%)
Hold 6|1|10|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
3.11
3.21
3.52
3.60
9.07%
13.96%
13.17%
12.53%
RevenueRp B
25.21
25.22
26.25
25.55
(3.05%)
(4.04%)
(0.68%)
(0.77%)
Peers (US$12.25M)
Cap (US$)
PE
86.37M
6.555x
21.57M
18.12x
12.30M
—
Capital
TTM
5Y
10Y
Leveragex
1.006
0.342
0.321
EBIT/Intx
0.571
0.173
0.166
Own earn%
0.25
76.87
69.71
Sh yield%
32.46
53.88
49.97
Owners
Insiders/Inst%
11.94
64.66
Short interest%
3.68
SBC / revenue%
1.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
19–29
$1 testx
—
Incr. ROIC%
11